FR2133024A5 - Bis-(4-nicotinoyloxyphenylthio) propanes - with hypocholesterolaemic and hypolipaemic activity - Google Patents

Bis-(4-nicotinoyloxyphenylthio) propanes - with hypocholesterolaemic and hypolipaemic activity

Info

Publication number
FR2133024A5
FR2133024A5 FR7112107A FR7112107A FR2133024A5 FR 2133024 A5 FR2133024 A5 FR 2133024A5 FR 7112107 A FR7112107 A FR 7112107A FR 7112107 A FR7112107 A FR 7112107A FR 2133024 A5 FR2133024 A5 FR 2133024A5
Authority
FR
France
Prior art keywords
bis
nicotinoyloxyphenylthio
hypocholesterolaemic
propanes
hypolipaemic activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7112107A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR7112107A priority Critical patent/FR2133024A5/fr
Application granted granted Critical
Publication of FR2133024A5 publication Critical patent/FR2133024A5/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
FR7112107A 1971-04-06 1971-04-06 Bis-(4-nicotinoyloxyphenylthio) propanes - with hypocholesterolaemic and hypolipaemic activity Expired FR2133024A5 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7112107A FR2133024A5 (en) 1971-04-06 1971-04-06 Bis-(4-nicotinoyloxyphenylthio) propanes - with hypocholesterolaemic and hypolipaemic activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7112107A FR2133024A5 (en) 1971-04-06 1971-04-06 Bis-(4-nicotinoyloxyphenylthio) propanes - with hypocholesterolaemic and hypolipaemic activity

Publications (1)

Publication Number Publication Date
FR2133024A5 true FR2133024A5 (en) 1972-11-24

Family

ID=9074816

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7112107A Expired FR2133024A5 (en) 1971-04-06 1971-04-06 Bis-(4-nicotinoyloxyphenylthio) propanes - with hypocholesterolaemic and hypolipaemic activity

Country Status (1)

Country Link
FR (1) FR2133024A5 (fr)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0637959A1 (fr) * 1992-04-30 1995-02-15 The Regents Of The University Of California Analogues solubles de probucol
US6121319A (en) * 1997-05-14 2000-09-19 Atherogenics, Inc. Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
US6670398B2 (en) 1997-05-14 2003-12-30 Atherogenics, Inc. Compounds and methods for treating transplant rejection
US6852878B2 (en) 1998-05-14 2005-02-08 Atherogenics, Inc. Thioketals and thioethers for inhibiting the expression of VCAM-1
US6881860B2 (en) 2000-04-11 2005-04-19 Atherogenics, Inc. Compounds and methods to increase plasma HDL cholesterol levels and improve HDL functionality
US6960683B2 (en) 2002-07-12 2005-11-01 Atherogenics, Inc. Salt forms of poorly soluble probucol esters and ethers
US7071158B2 (en) 1997-07-01 2006-07-04 Atherogenics, Inc. Antioxidant enhancement of therapy for hyperproliferative conditions
US7271274B2 (en) 2004-04-20 2007-09-18 Ahterogenics, Inc. Phenolic antioxidants for the treatment of disorders including arthritis, asthma and coronary artery disease
US7273948B2 (en) 2003-01-13 2007-09-25 Atherogenics, Inc. Process of preparing esters and ethers of probucol and derivatives thereof
US7294737B2 (en) 2004-04-20 2007-11-13 Atherogenics, Inc. Process of preparing esters and ethers of probucol and derivatives thereof
WO2008118948A1 (fr) 2007-03-26 2008-10-02 Atherogenics, Inc. Procédés et compositions de dérivés de probucol pour le traitement du diabète
US7687659B2 (en) 2005-04-21 2010-03-30 Salutria Pharmaceuticals Llc Process for the separation of probucol derivatives
US7897776B2 (en) 2007-04-23 2011-03-01 Salutria Pharmaceuticals Llc Sulfonamide containing compounds for treatment of inflammatory disorders

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1161946A3 (fr) * 1992-04-30 2003-12-10 AtheroGenics, Inc. Analogues solubles du Probucol
EP0637959A4 (fr) * 1992-04-30 1995-03-29 Univ California Analogues solubles de probucol.
EP0637959A1 (fr) * 1992-04-30 1995-02-15 The Regents Of The University Of California Analogues solubles de probucol
US6548699B1 (en) 1997-05-14 2003-04-15 Atherogenics, Inc. Compounds and methods for the inhibition of the expression of VCAM-1
US7375252B2 (en) 1997-05-14 2008-05-20 Atherogenics, Inc. Compounds and method for the inhibition of the expression of VCAM-1
US6602914B2 (en) 1997-05-14 2003-08-05 Atherogenics, Inc. Compounds and methods for the inhibition of the expression of VCAM-1
US6617352B2 (en) 1997-05-14 2003-09-09 Atherogenics, Inc. Compounds and methods for the inhibition of the expression of VCAM-1
US6147250A (en) * 1997-05-14 2000-11-14 Atherogenics, Inc. Compounds and methods for the inhibition of the expression of VCAM-1
US6670398B2 (en) 1997-05-14 2003-12-30 Atherogenics, Inc. Compounds and methods for treating transplant rejection
US6828447B2 (en) 1997-05-14 2004-12-07 Atherogenics, Inc. Compounds and methods for the inhibition of the expression of VCAM-1
US7189870B2 (en) 1997-05-14 2007-03-13 Atherogenic, Inc. Compounds and methods for the inhibition of the expression of VCAM-1
US7087645B2 (en) 1997-05-14 2006-08-08 Atherogenics, Inc. Compounds and methods for treating transplant rejection
US6121319A (en) * 1997-05-14 2000-09-19 Atherogenics, Inc. Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
US7071158B2 (en) 1997-07-01 2006-07-04 Atherogenics, Inc. Antioxidant enhancement of therapy for hyperproliferative conditions
US6852878B2 (en) 1998-05-14 2005-02-08 Atherogenics, Inc. Thioketals and thioethers for inhibiting the expression of VCAM-1
US6881860B2 (en) 2000-04-11 2005-04-19 Atherogenics, Inc. Compounds and methods to increase plasma HDL cholesterol levels and improve HDL functionality
US7183317B2 (en) 2000-04-11 2007-02-27 Atherogenics, Inc. Compounds and methods to increase plasma HDL cholesterol levels and improve HDL functionality
US6960683B2 (en) 2002-07-12 2005-11-01 Atherogenics, Inc. Salt forms of poorly soluble probucol esters and ethers
US7371895B2 (en) 2002-07-12 2008-05-13 Atherogenics, Inc. Salt forms of poorly soluble probucol esters and ethers
US7273948B2 (en) 2003-01-13 2007-09-25 Atherogenics, Inc. Process of preparing esters and ethers of probucol and derivatives thereof
US7622604B2 (en) 2003-01-13 2009-11-24 Salutria Pharmaceuticals Llc Process of preparing esters and ethers of probucol and derivatives thereof
US7294737B2 (en) 2004-04-20 2007-11-13 Atherogenics, Inc. Process of preparing esters and ethers of probucol and derivatives thereof
US7271274B2 (en) 2004-04-20 2007-09-18 Ahterogenics, Inc. Phenolic antioxidants for the treatment of disorders including arthritis, asthma and coronary artery disease
US7687659B2 (en) 2005-04-21 2010-03-30 Salutria Pharmaceuticals Llc Process for the separation of probucol derivatives
WO2008118948A1 (fr) 2007-03-26 2008-10-02 Atherogenics, Inc. Procédés et compositions de dérivés de probucol pour le traitement du diabète
US8252840B2 (en) 2007-03-26 2012-08-28 Salutria Pharmaceuticals Llc Methods of derivatives of probucol for the treatment of type II diabetes
US7897776B2 (en) 2007-04-23 2011-03-01 Salutria Pharmaceuticals Llc Sulfonamide containing compounds for treatment of inflammatory disorders

Similar Documents

Publication Publication Date Title
FR2133024A5 (en) Bis-(4-nicotinoyloxyphenylthio) propanes - with hypocholesterolaemic and hypolipaemic activity
NL177903B (nl) Op afstand bestuurbaar duiktoestel.
FR2134810A5 (en) Bis-(3-alkyl-5-t-alkyl-4-(thiazole-5-carboxy)phenylthio) alcanes - - with hypocholesterolaemic and hypolipaemic activity
FR2155856A1 (en) N-2 pyridylureas - with antiinflammatory and analgesic activity
GB1416740A (en) Amino-pyridines
FR2139628A1 (en) 5-(4-aryl piperazino-alkyl and alkylene) indans - with tranquillizing activity
FR2275455A1 (fr) Nouvelle methode de preparation de desoxyvincaminates d'hydroxy-2 alkyle
GB1359630A (en) Process for preparing 3-hydroxy-isoxazole derivatives
ES445144A1 (es) Procedimiento para la preparacion de compuestos derivados deindolobenzacepinas.
BE776576A (fr) Bruleur a oxygene,
SE387957B (sv) Forfarande for framstellning av en enzymatisk substans betecknad med nr 22750 rp genom odling av en ny organism benemnd streptomyces venetus
ES413816A1 (es) Procedimiento para preparar colorantes azoicos libres de grupos acido carboxilico y acido sulfonico.
FR2109005A1 (en) 4-(2-quinoxalyl)phenoxyacetic acids - diuretics and antiurics
FR2149275A1 (en) 4-(3-dialkylaminopropylamino)-1,3-dimethyl-1h-pyrazolo - (3,4-b) quinolines - with hypocholesterolaemic and hypolipaemic activ
CA952169A (en) Skin heating of steel by a.c.
CA997674A (en) Process of scrubbing gases with reheat of effluent gases
FR2078729A5 (en) Herbicidal 2,4-bis-trifluoromethyl-6-nitro-anilines
FR2146137A1 (en) 1,10-diaminoethylthio decanes - hypotensives
GB927497A (en) New 5-nitrofuran derivatives
FR2090640A5 (en) 1-thiazolyl-3-sulphenyl-ureas
FR2254315A1 (en) 1-Alpha-naphthoxy-3-amino-prop-2-yl nicotinates - with hypolipaemic antiarrhythmic and cardiovascular protective activity
BE769091A (fr) Derive de la raubasine.
GB1444553A (en) Aminoethanols
FR2143526A1 (en) 3-carboxy-4-salicyloxy-6-sulphamoylquinolines - with analgesic,antiinflammatory, antipyretic, antirheumatic activity
JPS5251159A (en) Fluid mixer

Legal Events

Date Code Title Description
ST Notification of lapse